Anticancer Properties of Plectranthus ornatus-Derived Phytochemicals Inducing Apoptosis via Mitochondrial Pathway

Przemysław Sitarek1, Ewelina Synowiec2, Tomasz Kowalczyk3

  • 1Department of Biology and Pharmaceutical Botany, Medical University of Lodz, ul. Muszyńskiego 1, 90-151 Lodz, Poland.

Insights

Plant-derived compounds halimane (HAL) and labdane diterpenes (PLEC) show anticancer potential against MCF7 and FaDu cells. These natural products induce apoptosis via mitochondrial pathways with no observed in vivo toxicity.

Area of Science:

  • Natural Product Chemistry
  • Cancer Biology
  • Pharmacology

Background:

  • Radio- and chemotherapy pose safety concerns, necessitating novel anticancer agents.
  • Plant-derived compounds are promising sources for alternative anticancer drug discovery.

Purpose of the Study:

  • To investigate the anticancer properties of halimane (HAL) and labdane diterpenes (PLEC) from *Plectranthus ornatus*.
  • To evaluate their effects on cancer cell viability, mitochondrial function, and apoptosis pathways in MCF7 and FaDu cell lines.

Main Methods:

  • Cytotoxicity assessed via MTT assay.
  • Reactive oxygen species (ROS) production, mitochondrial membrane potential (MMP), and mitochondrial DNA (mtDNA) damage quantified.
  • Gene expression of apoptosis-related genes analyzed using qRT-PCR.
  • Caspase-3/7 activity and in vivo toxicity evaluated.

Main Results:

  • HAL and PLEC exhibited significant cytotoxicity in MCF7 and FaDu cells.
  • Compounds increased ROS production, induced mitochondrial damage (ND1, ND5 genes), and reduced MMP and mtDNA copy numbers.
  • Apoptosis-related gene expression was altered, and caspase 3/7 activity increased.
  • No general in vivo toxicity observed in Brine Shrimp Lethality Bioassay.

Conclusions:

  • HAL and PLEC demonstrate anticancer potential by inducing apoptosis through the mitochondrial pathway.
  • These compounds represent promising candidates for further investigation as natural anticancer drugs.
  • Further in vivo studies are warranted to elucidate comprehensive mechanisms and therapeutic potential.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.5K